Patient characteristics and disposition
gastroesophageal junction carcinoma, thymic carcinoma, small-cell lung cancer, prostate cancer
ESOPHAGEAL CANCER, PROSTATE CANCER, GASTRIC CARCINOMA, NASOPHARYNGEAL CARCINOMA, MAY, THYMIC CARCINOMA, ONCOLOGY, RECTAL CANCER, DISEASE CHARACTERISTIC
Between 29 May 2019 and 24 July 2020, 40 patients were screened and 35 eligible patients were enrolled and treated with QL1604 (Study design and patient disposition. Baseline demographics and disease characteristics (full analysis set).NSCLC, non–small-cell lung cancer; EC, esophageal cancer; GC, gastric carcinoma; GEJC, gastroesophageal junction carcinoma; ECOG, Eastern Cooperative Oncology Group.*Including small-cell lung cancer (four patients), nasopharyngeal carcinoma (three patients), thymic carcinoma (one patient), prostate cancer (one patient), and rectal cancer (one patient).